NHLBI TOPMed: Pathways to Immunologically Mediated Asthma (PIMA)
Anthropometry (1)
- BMI - Body Mass Index calculated from Height and Weight (phv00430101.v1.p1)
Demographics (3)
- AGE - Subject age (phv00430098.v1.p1)
- SEX - Gender of participant (phv00430099.v1.p1)
- SEX - Genetic Sex (phv00531570.v1.p1)
General Health (1)
- asthma_hospital_Yes12mo - In the last 12 months, has participant been hospitalized because of asthma? (phv00430104.v1.p1)
Medications (1)
- steroids_Yes12mo - In the last 12 months, has participant been prescribed oral steroids (such as prednisone pills or prelone liquid) to help control asthma? (phv00430105.v1.p1)
Race and Ethnicity (1)
- Race - Race of participant (phv00430100.v1.p1)
Respiratory (1)
- delta1 - Bronchodilator Response after 4 puffs of Proventil HFA Albuterol (phv00430106.v1.p1)
Substance Use (1)
- smoke_current - Does participant currently smoke at least 1 cig per day? (phv00430103.v1.p1)
Other (15)
- Affection_Status - Case or Control for asthma (phv00430102.v1.p1)
- ANALYTE_TYPE - Analyte Type (phv00430109.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00430108.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00430093.v1.p1)
- Funding_Source - Project funding source (phv00430112.v1.p1)
- IS_TUMOR - Tumor status (phv00430110.v1.p1)
- SAMPLE_ID - Sample ID (phv00430107.v1.p1)
- SAMPLE_ID - Sample ID (phv00430096.v1.p1)
- SEQUENCING_CENTER - Name of the center which conducted sequencing (phv00430111.v1.p1)
- Study_Name - TOPMed-assigned short study name (1:1 with TOPMed phs number) (phv00430115.v1.p1)
- SUBJECT_ID - De-identified Subject ID (phv00430097.v1.p1)
- SUBJECT_ID - Subject ID (phv00430092.v1.p1)
- SUBJECT_ID - Subject ID (phv00430095.v1.p1)
- TOPMed_Phase - TOPMed Phase (phv00430113.v1.p1)
- TOPMed_Project - TOPMed Project that funded sequencing (phv00430114.v1.p1)